Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Mello

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
BMJ Medicine|March 20, 2023
Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional studyTanvee Varma, Michelle Mello, Joseph S Ross, et al.
SSM - Population Health|March 7, 2022
Population health science as a unifying foundation for translational clinical and public health researchMark R Cullen, Michael Baiocchi, Lisa Chamberlain, et al.
JCO Oncology Practice|June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over TimeJennifer E Miller, William Pelletiers, Cary P Gross, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
BMJ Medicine|March 20, 2023
Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional studyTanvee Varma, Michelle Mello, Joseph S Ross, et al.
SSM - Population Health|March 7, 2022
Population health science as a unifying foundation for translational clinical and public health researchMark R Cullen, Michael Baiocchi, Lisa Chamberlain, et al.
JCO Oncology Practice|June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over TimeJennifer E Miller, William Pelletiers, Cary P Gross, et al.
Pageof 2